The Great Rule Breakers Healthcare Debate: Progyny or Hims & Hers?

In this episode of Motley Fool Money, Tim Beyers hosts a debate between Sanmeet Deo and Alicia Alfiere, comparing Progyny (PGNY) and Hims & Hers (HIMS) as potential healthcare investments, with Tim ultimately favoring Progyny due to regulatory concerns surrounding Hims & Hers. The panel then discusses NVIDIA's $5 billion investment in Intel, analyzing the strategic implications for both companies and concluding it's a potentially bigger deal for Intel. Finally, the hosts reflect on the principles of Rule Breaker Investing, inspired by David Gardner's new book, sharing personal anecdotes about how the philosophy has shaped their investment approaches.